Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Oliver Young
Observed names:
Oliver E. Young,
Young, Oliver
Institution:
Western General Hospital
Observed institutions:
Novartis (Switzerland),
NHS Lothian,
University of Nottingham,
Institute of Cancer Research,
Washington University in St. Louis,
Western General Hospital,
Royal Marsden Hospital,
Duke Medical Center,
The Christie Hospital,
University of Edinburgh
show all 10
OpenAlex ID:
A5110052747
Estrogen-Independent Proliferation Is Present in Estrogen-ReceptorHER2-Positive Primary Breast Cancer After Neoadjuvant Letrozole
2006
·
Matthew J. Ellis
, Yu Tao
, et al.
·
Journal of Clinical Oncology
·
173
Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer
2008
·
J. Michael Dixon
, Lorna Renshaw
, et al.
·
Journal of Clinical Oncology
·
160
PDF
Molecular response to aromatase inhibitor treatment in primary breast cancer
2007
·
Alan Mackay
, Ander Urruticoechea
, et al.
·
Breast Cancer Research
·
122
PDF
Increase in response rate by prolonged treatment with neoadjuvant letrozole
2008
·
J. Michael Dixon
, Lorna Renshaw
, et al.
·
Breast Cancer Research and Treatment
·
111
Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction
2020
·
S Potter
, A Trickey
, et al.
·
British journal of surgery
·
40
PDF
Cyclooxygenase-2 Inhibition Does Not Improve the Reduction in Ductal Carcinoma In situ Proliferation with Aromatase Inhibitor Therapy: Results of the ERISAC Randomized Placebo-Controlled Trial
2010
·
Nigel J. Bundred
, Angela Cramer
, et al.
·
Clinical Cancer Research
·
40
A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer
2009
·
Fiona M. McCaig
, Lorna Renshaw
, et al.
·
Breast Cancer Research and Treatment
·
35
Patients’ Views of Treatment‐Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing
2018
·
Sarah Wright
, Mary Porteous
, et al.
·
Journal of Genetic Counseling
·
32
PDF
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability
2010
·
J. Michael Dixon
, Lorna Renshaw
, et al.
·
Breast Cancer Research and Treatment
·
24
Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an ‘oncogenetic taskscape’
2019
·
Sarah Wright
, Mary Porteous
, et al.
·
Social Science & Medicine
·
18
Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies
2019
·
J. Michael Dixon
, David A. Cameron
, et al.
·
Advances in Therapy
·
15
DCIS and aromatase inhibitors
2007
·
J. Michael Dixon
, Dana Faratian
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
10
Surgical issues surrounding use of aromatase inhibitors
2005
·
J. Michael Dixon
, Lorna Renshaw
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
7
P097. Intra-operative assessment of excision margins in breast conserving surgery for breast cancer using ClearEdge imaging device
2015
·
J. Michael Dixon
, Lorna Renshaw
, et al.
·
European Journal of Surgical Oncology
·
6
No evidence of benefit for laminar flow in theatre for sling-assisted, implant-based breast reconstruction
2020
·
Matthew D. Barber
, Oliver Young
, et al.
·
The Surgeon
·
2
Outcomes from the Scottish audit of oncoplastic breast conservations: surgical techniques, incomplete excision rate and complications – Analysis of 498 patients from 11 units
2017
·
Laszlo Romics
, Jane Macaskill
, et al.
·
European Journal of Surgical Oncology
·
1
Abstract P3-06-35: Association of estrogen receptor (ER) levels and prediction of antiproliferative effect of hormone therapy (HT) in lower ER-expressing tumors
2015
·
J Michael Dixon
, Arran Turnbull
, et al.
·
Cancer Research
·
1
P011. Axillar management after Neo-adjuvant chemotherapy: Edinburgh Breast Unit 2016-17 period
2019
·
Sarah Moin
, Teresa Fernandez
, et al.
·
European Journal of Surgical Oncology
BRCA 1/2 mutation carriers' audit. Surveillance and preventive intervention amongst affected and unaffected groups during 2004–2016 period
2018
·
Teresa Fernandez
, Oliver Young
, et al.
·
European Journal of Surgical Oncology
P060. Inflammatory breast cancer diagnosed between 2007–2013 in the Edinburgh Breast Unit – Multimodality treatment and outcomes
2015
·
Monika Brzezinska
, Lucy Khan
, et al.
·
European Journal of Surgical Oncology
P100. Management of positive sentinel node biopsy. Audit of practice 2010–2012
2015
·
Teresa Fernandez
, Elizabeth Vaughan
, et al.
·
European Journal of Surgical Oncology
Abstract P1-16-05: Intra-operative imaging of surgical margins in breast conserving surgery using localized tissue dielectric response
2015
·
J Michael Dixon
, Lorna Renshaw
, et al.
·
Cancer Research
Show more works
View as search
Works count:
24
Citation count:
837
H-index:
12
I10-index:
13
Year
Topic
Type